BAMS

Bellevue Asset Management (Switzerland)’s Celldex Therapeutics CLDX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$2.51M	Hold	160,000	–	–	0.38%	75
2015 Q3	$1.69M	Buy	160,000 +86,000	+116%	+$906K	0.28%	91
2015 Q2	$1.87M	Sell	74,000 -30,000	-29%	-$756K	0.26%	87
2015 Q1	$2.61M	Buy	+104,000	New	+$2.61M	0.36%	69